newest glp 1 drug Novo's Wegovy becomes first GLP-1 approved for MASH List of approved and pending

Government healthcare policies and regulations regarding drug pricing and reimbursement play a critical role in determining the affordability and market penetration of GLP-1 receptor agonists

There is also a need to know if all GLP-1Ra have the same impact on bone outcomes

RyR2: the type 2 ryanodine receptor

Although GLP-1 drugs are generally considered safe to use, its recommended to avoid them if you have or had: Personal or family history of thyroid cancer Family history of multiple endocrine neoplasia 2 (MEN-2) Pancreatitis Used other anti-obesity medications These medications can aggravate the above conditions, which may lead to serious health complications

References: Charbonnel B, Cariou B (2011): Pharmacological management of type 2 diabetes: the potential of incretin-based therapies

Mann JF, Anderson C, Gao P, Gerstein HC, Boehm M, Ryden L, et al